Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia L Hurwitz

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
Viral Immunology|February 15, 2018
Antiviral Vaccines: Successes and ProspectsJulia L Hurwitz
Expert Review of Vaccines|October 13, 2011
Respiratory syncytial virus vaccine developmentJulia L Hurwitz
The Pediatric Infectious Disease Journal|October 23, 2008
Development of recombinant Sendai virus vaccines for prevention of human parainfluenza and respiratory syncytial virus infectionsJulia L Hurwitz
Viral Immunology|April 30, 2020
B Cells, Viruses, and the SARS-CoV-2/COVID-19 Pandemic of 2020Julia L Hurwitz
Current Drug Targets. Infectious Disorders|June 25, 2005
HIV vaccine discovery and developmentJulia L Hurwitz
Journal of Immunological Methods|January 17, 2002
A highly sensitive single-cell assay detects T-helper cell responses missed by conventional interleukin-2-based methodsSherri Surman, Julia L Hurwitz
Leukemia & Lymphoma|June 14, 2003
Customized mitogen or antibody treatments enhance the sensitivity of lymphoid tumors to 5-fluorouracil in vitro and in vivoSybil D'Costa, Julia L Hurwitz
Mbio|February 25, 2016
Unveiling Unexpected Immune Activities Induced by Your Pneumococcal VaccineJulia L Hurwitz, Elaine Tuomanen
Viral Immunology|January 10, 2018
Multi-Envelope HIV-1 Vaccine Development: Two Targeted Immune Pathways, One Desired Protective OutcomeJulia L Hurwitz, Mattia Bonsignori
Microorganisms|August 27, 2021
Cross-Reactive Immune Responses toward the Common Cold Human Coronaviruses and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Mini-Review and a Murine StudyRobert E Sealy, Julia L Hurwitz
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
Viral Immunology|February 15, 2018
Antiviral Vaccines: Successes and ProspectsJulia L Hurwitz
Expert Review of Vaccines|October 13, 2011
Respiratory syncytial virus vaccine developmentJulia L Hurwitz
The Pediatric Infectious Disease Journal|October 23, 2008
Development of recombinant Sendai virus vaccines for prevention of human parainfluenza and respiratory syncytial virus infectionsJulia L Hurwitz
Viral Immunology|April 30, 2020
B Cells, Viruses, and the SARS-CoV-2/COVID-19 Pandemic of 2020Julia L Hurwitz
Current Drug Targets. Infectious Disorders|June 25, 2005
HIV vaccine discovery and developmentJulia L Hurwitz
Journal of Immunological Methods|January 17, 2002
A highly sensitive single-cell assay detects T-helper cell responses missed by conventional interleukin-2-based methodsSherri Surman, Julia L Hurwitz
Leukemia & Lymphoma|June 14, 2003
Customized mitogen or antibody treatments enhance the sensitivity of lymphoid tumors to 5-fluorouracil in vitro and in vivoSybil D'Costa, Julia L Hurwitz
Mbio|February 25, 2016
Unveiling Unexpected Immune Activities Induced by Your Pneumococcal VaccineJulia L Hurwitz, Elaine Tuomanen
Viral Immunology|January 10, 2018
Multi-Envelope HIV-1 Vaccine Development: Two Targeted Immune Pathways, One Desired Protective OutcomeJulia L Hurwitz, Mattia Bonsignori
Microorganisms|August 27, 2021
Cross-Reactive Immune Responses toward the Common Cold Human Coronaviruses and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Mini-Review and a Murine StudyRobert E Sealy, Julia L Hurwitz
Pageof 12